期刊文献+

应用组织型纤溶酶原激活物-抑制剂复合物评价脓毒症严重程度的临床价值 被引量:9

Clinical value of tissue-type plasminogen activator-inhibitor complexes to evaluate the severity of sepsis
下载PDF
导出
摘要 目的内毒素和低灌注可导致脓毒症患者血管内皮细胞损害,进而引起组织型纤溶酶原激活物-抑制剂复合物(t-PAIC)水平显著升高。文中探讨t-PAIC用于评价脓毒症严重程度的临床价值。方法选择2018年5月至2019年10月解放军联勤保障部队第九〇八医院重症医学科收治的163例脓毒症患者,按照脓毒症3.0诊断标准分为脓毒症组(n=104)和脓毒性休克组(n=59),比较2组患者的t-PAIC水平变化。结果与脓毒症组患者[10.75(7.10~16.30)ng/mL]相比,脓毒性休克组患者的t-PAIC[35.20(18.60~48.10)ng/mL]显著升高(P<0.001)。Spearson相关分析显示脓毒症患者乳酸水平、序贯器官衰竭评分(SOFA)与t-PAIC水平均呈正相关(r分别为0.56、0.50,P<0.001)。单因素logistic回归显示,t-PAIC(OR=1.11,95%CI 1.071~1.144,P<0.001)与脓毒性休克的发生相关。t-PAIC诊断脓毒性休克的曲线下面积为0.858(P<0.001),灵敏度、特异度、阳性预测值和阴性预测值分别为0.780、0.788、0.676、0.863。根据其Cut-off值分组显示t-PAIC<18.2 ng/mL的急性生理与慢性健康评分、SOFA评分、乳酸水平及弥散性血管内凝血发生率较t-PAIC≥18.2 ng/mL组患者明显降低(P<0.05),且t-PAIC<18.2 ng/mL的生存率较t-PAIC≥18.2 ng/mL组患者升高约2.2倍。结论t-PAIC与脓毒症严重程度相关。t-PAIC≥18.2 ng/mL脓毒症患者病死率明显升高。 Objective Sepsis patients with bacterial endotoxin and low perfusion can lead to vascular endothelial cell damage,resulting in a significant increase of the the tissue-type plasminogen activator-inhibitor complexes(tPAIC)levels.In this paper,we discuss the clinical value of tPAIC to evaluate the severity of sepsis.Methods A total of 163 sepsis patients admitted to the ICU Department of the 908th Hospital of the Chinese PLA Joint Logistic Support Force from May 2018 to October 2019 were analyzed.They were divided into two groups according to 3.0 criteria for the diagnosis of sepsis:sepsis group(n=104)and septic shock group(n=59),and the tPAIC level changes were compared in these two groups.Results tPAIC[35.20(18.60-48.10 ng/mL)]was significantly higher(P<0.001)in the patients with sepsis shock group[10.75(7.10-16.30 ng/mL)],compared to patients with septic group.Spearson correlation analysis showed that both lactic acid levels in patients with sepsis and sequential organ failure assessment(SOFA)were positively correlated with tPAIC levels(r as 0.56 and 0.50 respectively,P<0.001).Single factor logistic regression showed that tPAIC(OR=1.11,95%CI 1.071 to 1.144,P<0.001)was associated with the occurrence of septic shock.tPAIC area under the curve of the diagnosis of septic shock was 0.858(P<0.001),and the sensitivity,specificity,positive predictive value and negative predictive value was 0.780,0.788,0.676,0.863,respectively.The Cut-off showed that the acute physiology and chronic health evaluation,SOFA,lactic acid levels and the incidence of diffuse intravascular coagulation of tPAIC<18.2 ng/mL decreased significantly compared to those of the tPAIC<18.2 ng/mL(P<0.05),and the survival rate of the patients in tPAIC<18.2 ng/mL increased 2.2 times than that of the patients in tPAIC≥18.2 ng/mL.Conclusion tPAIC is associated with sepsis severity and the fatality rate of the sepsis patients in the tPAIC acuity 18.2 ng/mL increased significantly.
作者 钟林翠 宋景春 姜峻 胡艳晶 何龙平 李兆芳 ZHONG Lin-cui;SONG Jing-chun;JIANG Jun;HU Yan-jing;HE Long-ping;LI Zhao-fang(Intensive Care Unit,908th Hospital of Chinese PLA Logistical Support Force,Nanchang 330002,Jiangxi,China)
出处 《医学研究生学报》 CAS 北大核心 2020年第11期1176-1180,共5页 Journal of Medical Postgraduates
基金 南京军区重点科技创新项目(2013ZD22)。
关键词 组织型纤溶酶原激活物-抑制剂复合物 脓毒症 休克 tissue plasminogen activator-inhibitor complex sepsis shock
  • 相关文献

参考文献4

二级参考文献18

  • 1Whiting PS, Jahangir AA. Thromboembolic Disease After Orthopedic Trauma[J]. Orthop Clin North Am, 2016,47 (2): 335-344.
  • 2Wu PK, Chen CF, Chung LH, et al. Population-based epidemiology of postoperative venous thromboembolism in Taiwan Residents patients receiving hip or knee arthroplasty without pharmacological thromboprophylaxis[ J]. Thromb Res, 2014,133 (5) :719-724.
  • 3Wood RC, Stewart DW, Slusher L, et al. Retrospective Evaluation of Postoperative Bleeding Events in Patients Receiving Rivaroxaban After Undergoing Total Hip and Total Knee Arthroplasty: Comparison with Clinical Trial Data [ J ]. Pharmacotherapy, 2015,35 ( 7 ) : 663-669.
  • 4Granziera S, Cohen AT. VTE primary prevention, including hospitalised medical and orthopaedic surgical patients [ J ]. Thromb Haemost, 2015,113 (6) : 1216-1223.
  • 5Dahl OE, Harenberg J, Wexels F, et al. Arterial and venous thrombosis following trauma and major orthopedic surgery: molecular mechanisms and strategies for intervention [ J ]. Semin Thromb Hemost, 2015,41 (2) :141-145.
  • 6Su EP, Chatzoudis N, Sioros V, et al. Markers of thrombin generation during resurfaeing and noncemented total hip arthroplasty: a pilot study[ J]. Clin Orthop Relat Res, 2011,469 (2) :535-540.
  • 7Hughes SF, Hendricks BD, Edwards DR, et al. Total hip and knee replacement surgery results in changes in leukocyte and endothelial markers [ J ]. J Inflamm ( Lond), 2010,7 : 2.
  • 8Fedi S, Gori AM, Falciani M, et al. Procedure-dependence and tissue factor-independence of hypercoagulability during orthopaedic surgery[J]. Thromb Haemnst, 1999,81 (6) :874-878.
  • 9Cofrancesco E, Cortellaro M, Corradi A, et al. Coagulation activation markers in the prediction of venous thrombosis after elective hip surgery [ J]. Thromb Haemost, 1997,77 ( 2 ) : 267- 269.
  • 10Lazo-Langner A, Fleet JL, McArthur E, et al. Rivaroxaban vs. low molecular weight heparin for the prevention of venous thromboembolism after hip or knee arthroplasty: a cohort study [J]. J Thromb Haemost, 2014,12(10) :1626-1635.

共引文献200

同被引文献38

引证文献9

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部